Snowflake ( ) released its third-quarter earnings yesterday, posting results that topped Wall Street estimates. Product revenue climbed 28% year-over-year to $1.21 billion, while adjusted earnings hit $0.35 per share, beating the consensus estimate of $0.31. Yet, the stock plunged 11% in midday trading today as investors fixated on the company's fourth-quarter guidance .
As artificial intelligence becomes a buzzword in nearly every healthcare startup pitch, investors are finding it increasingly challenging to distinguish which ones are actually worth the hype. That's why, during a Thursday panel discussion among venture capitalists at the MedCity INVEST Digital Health conference in Dallas, this question was posed: What metrics do you want to see founders highlighting more often when they're pitching, and what is one red flag that makes you question the validity of their technology? The session was moderated by Neil Patel, head of ventures at Redesign Health.